Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Verena Nilius"'
Autor:
Enver Aydilek, Susanne Klein-Scory, Julia Thomson, Verena Nilius-Eliliwi, Deepak Vangala, Roland Schroers, Gerald Wulf, Thomas Mika
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e949 (2023)
Externí odkaz:
https://doaj.org/article/431080bd890e41c6aeded3c7b4d65385
Publikováno v:
Neurological Research and Practice, Vol 5, Iss 1, Pp 1-11 (2023)
Abstract Background Treatment of relapsed or refractory primary CNS lymphoma (r/r PCNSL) is difficult, particularly in patients not eligible for high dose chemotherapy with autologous stem cell transplantation (HDC-ASCT). No standard treatment has be
Externí odkaz:
https://doaj.org/article/4ee914dac12f43c096e196bd5866ab58
Autor:
Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, Deepak Vangala, Meng Wang, Sabine Seidel, Thomas Mika, Dominik Marschner, Vanja Zeremski, Rebecca Wurm-Kuczera, Leandra Caillé, Claudia I. Chapuy, Lorenz Trümper, Thomas Fischer, Michael Altenbuchinger, Gerald G. Wulf, Gerald Illerhaus, Sascha Dietrich, Roland Schroers, Björn Chapuy
Publikováno v:
HemaSphere, Vol 7, Iss 8, p e926 (2023)
Secondary central nervous system lymphoma (SCNSL) is a rare and difficult to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively trea
Externí odkaz:
https://doaj.org/article/e74a68f6168d4ee3a17dc8e62bf03165
Autor:
Thomas Mika, Julia Thomson, Verena Nilius-Eliliwi, Deepak Vangala, Alexander Baraniskin, Gerald Wulf, Susanne Klein-Scory, Roland Schroers
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 539-550 (2021)
Chimeric antigen receptor (CAR)-T cells are increasingly used for the treatment of hematologic malignancies. Treatment success relies highly upon sufficient expansion of CAR-T effector cells. Accordingly, longitudinal quantification of CAR-T cells du
Externí odkaz:
https://doaj.org/article/05e6edc5484e40d886ac9ef87c30d4ee
Autor:
Verena Nilius-Eliliwi, Marco Tembrink, Wanda Maria Gerding, Krzystof P. Lubieniecki, Joanna M. Lubieniecka, Stefanie Kankel, Thomas Liehr, Thomas Mika, Fotios Dimopoulos, Konstanze Döhner, Roland Schroers, Hoa Huu Phuc Nguyen, Deepak Ben Vangala
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
In acute myeloid leukemia (AML), treatment decisions are currently made according to the risk classification of the European LeukemiaNet (ELN), which is based on genetic alterations. Recently, optical genome mapping (OGM) as a novel method proved to
Externí odkaz:
https://doaj.org/article/239df1092c224ff3a861dde340cd6900
Autor:
Deepak B. Vangala, Verena Nilius-Eliliwi, Thomas Mika, Thilo Gambichler, Rene Stranzenbach, Roland Schroers
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/c24dad81770946bca2ffacd09ecb9a61
Autor:
Verena Nilius-Eliliwi, Thomas Mika, Alexander Baraniskin, Max Wünnenberg, Marina Maslova, Christian Boy, Susanne Klein-Scory, Roland Schroers, Deepak Vangala
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
In patients with compromised immune function, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (CoVID-19) impose particular challenges. Especially in hematological malignancies, including lymphoma, t
Externí odkaz:
https://doaj.org/article/94ccd9398fe04ac880aa263f580c202a
Autor:
Verena Nilius, Madeleine C. Killer, Nina Timmesfeld, Melina Schmitt, Roland Moll, Anja Lorch, Jörg Beyer, Elisabeth Mack, Michael Lohoff, Andreas Burchert, Andreas Neubauer, Cornelia Brendel
Publikováno v:
OncoImmunology, Vol 7, Iss 5 (2018)
Survival of patients with germ-cell cancer (GCC) and primary progression or relapse after cisplatin-based first-line chemotherapy is highly heterogeneous, ranging from close to zero to more than 70%. We investigated β-1,4-Galactosyltransferase-I (B4
Externí odkaz:
https://doaj.org/article/b2074d733f4e4969b76dca9ac4466552
Publikováno v:
Leukemia & Lymphoma. 63:2905-2911
Although10% of primary CNS lymphoma (PCNSL) patients are ≥80 years, data on this population are limited. We analyzed 19 consecutive octogenarians with PCNSL treated with high-dose methotrexate (HD-MTX)-based chemotherapy at our institution concerni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5c6e5671813beca8de897c7069bb00
https://doi.org/10.1080/10428194.2022.2100371
https://doi.org/10.1080/10428194.2022.2100371
Autor:
Jonas Althaus, Verena Nilius-Eliliwi, Abdelouahid Maghnouj, Sascha Döring, Roland Schroers, Michael Hudecek, Stephan A. Hahn, Thomas Mika
Publikováno v:
Cancer Immunology, Immunotherapy.
Chimeric antigen receptors (CARs) have improved cancer immunotherapy in recent years. Immune cells, such as Natural killer cells (NK-cells) or T cells, are used as effector cells in CAR-therapy. NK92-cells, a cell line with known cytotoxic activity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4a85d545b468bf8c226bd307333087a
https://doi.org/10.1007/s00262-023-03443-1
https://doi.org/10.1007/s00262-023-03443-1